CHARACTERIZATION AND IMMUNOGENICITY OF A CANDIDATE SUBUNIT VACCINE AGAINST VARICELLA-ZOSTER VIRUS

被引：17

作者：

DAVIES, J ^{[1
]}

HALLWORTH, JA ^{[1
]}

MCLEISH, P ^{[1
]}

RANDALL, S ^{[1
]}

MARTIN, BAB ^{[1
]}

BUCHAN, A ^{[1
]}

SKINNER, GRB ^{[1
]}

机构：

[1] UNIV BIRMINGHAM,SCH MED,DEPT INFECT,BIRMINGHAM B15 2TJ,W MIDLANDS,ENGLAND

来源：

MEDICAL MICROBIOLOGY AND IMMUNOLOGY | 1994年 / 183卷 / 02期

关键词：

D O I：

10.1007/BF00277161

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This study describes the properties of an inactivated subunit antigen preparation from varicella-zoster virus (VZV)-infected MRC-5 cells by treatment with detergent and formaldehyde, ultracentrifugation over sucrose and acetone precipitation. The method preserved the antigenicity of VZV proteins and several VZV-specific glycoproteins, while virus DNA was less than 20 pg/250 mu g protein - a putative vaccine dose. The vaccine was immunogenic in rabbits and stimulated antibodies to the major capsid protein as well as to glycoproteins; an immunoprecipitin was shared with a known immune human serum. The preparation contained no infectious VZV with no evidence of side effects in a rabbit or in five human vaccinees during a follow-up period of 6 - 10 years.

引用

页码：105 / 117

页数：13

共 50 条

[1] ANTIGENICITY OF A CANDIDATE VARICELLA-ZOSTER VIRUS GLYCOPROTEIN SUBUNIT VACCINE
VAFAI, A
[J]. VACCINE, 1993, 11 (09) : 937 - 940
[2] Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults ≥50 Years of Age
Chlibek, Roman
Bayas, Jose M.
Collins, Harry
Rodriguez de la Pinta, Maria Luisa
Ledent, Edouard
Mols, Johann F.
Heineman, Thomas C.
[J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (12): : 1953 - 1961
[3] BOOSTING IMMUNE-RESPONSE WITH A CANDIDATE VARICELLA-ZOSTER VIRUS GLYCOPROTEIN SUBUNIT VACCINE
VAFAI, A
[J]. VACCINE, 1995, 13 (14) : 1336 - 1338
[4] SAFETY AND IMMUNOGENICITY OF VARICELLA-ZOSTER VIRUS (VZV) VACCINE IN ADULTS
KUMAR, ML
COLLINS, MS
GOPALAKRISHNA, KV
[J]. PEDIATRIC RESEARCH, 1986, 20 (04) : A313 - A313
[5] Varicella-zoster virus vaccine
White, CJ
[J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (05) : 753 - 761
[6] Concerns on Vaccine against Varicella Caused by Varicella-Zoster Virus Infection
Zeng, Wen-Bo
Zhang, Fukun
Cheng, Shuang
Sun, Jin-yan
Shen, Hongjie
Luo, Min-Hua
[J]. VIROLOGICA SINICA, 2021, 36 (01) : 159 - 162
[7] Concerns on Vaccine against Varicella Caused by Varicella-Zoster Virus Infection
Wen-Bo Zeng
Fukun Zhang
Shuang Cheng
Jin-yan Sun
Hongjie Shen
Min-Hua Luo
[J]. Virologica Sinica, 2021, 36 (01) : 159 - 162
[8] Varicella vaccine and infection with varicella-zoster virus
Vázquez, M
Shapiro, ED
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (05): : 439 - 440
[9] Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults ≥50 Years of Age (vol 208, pg 1953, 2013)
Chlibek, Roman
Bayas, Jose M.
Collins, Harry
de la Pinta, Maria Luisa Rodriguez
Ledent, Edouard
Mols, Johann F.
Heineman, Thomas C.
[J]. JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (02): : 353 - 353
[10] VARICELLA-ZOSTER VIRUS-VACCINE
SABIN, AB
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 238 (16): : 1731 - 1733

← 1 2 3 4 5 →